- Home
- HCKT vs MLAB Comparison
HCKT vs MLAB Comparison
Compare HCKT & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCKT | MLAB |
|---|---|---|
| Founded | 1991 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 392.0M | 489.8M |
| IPO Year | 1998 | 1995 |
Fundamental Metrics
Financial Performance| Metric | HCKT | MLAB |
|---|---|---|
| Price | $13.85 | $77.96 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $17.00 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 343.8K | 103.3K |
| Earning Date | 05-19-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.40% | 0.82% |
| EPS Growth | N/A | ★ 99.24 |
| EPS | 0.46 | ★ 1.95 |
| Revenue | ★ $285,862,000.00 | N/A |
| Revenue This Year | $2.55 | $6.07 |
| Revenue Next Year | $5.07 | $5.41 |
| P/E Ratio | ★ $30.67 | $39.90 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.76 | $59.63 |
| 52 Week High | $29.52 | $130.12 |
Technical Indicators
Market Signals| Indicator | HCKT | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 39.18 | 35.48 |
| Support Level | $12.76 | $77.23 |
| Resistance Level | $21.13 | $81.62 |
| Average True Range (ATR) | 0.51 | 4.13 |
| MACD | 0.20 | -2.09 |
| Stochastic Oscillator | 44.39 | 25.90 |
Price Performance
Historical ComparisonAbout HCKT Hackett Group Inc (The).
The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.